---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-061483"
form_type: "8-K"
ticker: "AVAH"
cik: "0001832332"
company_name: "Aveanna Healthcare Holdings, Inc."
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T07:33:53.598952+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aveanna Q3 revenue up 7.9% to $478M; net loss $102.4M on $105.1M impairment; raises FY guidance

## Summary
- Revenue $478.0M (+7.9% YoY); gross margin $147.3M (+9.4%).
- Net loss $102.4M includes $105.1M non-cash goodwill impairment vs net income $24.3M in Q3 2022.
- Adjusted EBITDA $36.2M (+46.2% YoY); adjusted net loss per share $(0.03) unchanged.
- FY 2023 revenue guidance raised to $1.87B-$1.88B; Adj. EBITDA guidance raised to $134M-$137M.
- CEO cites continued momentum and execution on 2023 initiatives.

## SEC filing metadata
- accession: 0000950170-23-061483
- form_type: 8-K
- ticker: AVAH
- cik: 0001832332
- company_name: Aveanna Healthcare Holdings, Inc.
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832332/000095017023061483/0000950170-23-061483-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832332/000095017023061483/avah-20231109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-061483
- JSON: https://secwatch.observer/filing/0000950170-23-061483.json
- Plain text: https://secwatch.observer/filing/0000950170-23-061483.txt

## Key facts
- Earnings Releases
  Aveanna Healthcare Holdings, Inc. reported three and nine-month periods ended September 30, 2023 results: revenue $478.0 million, net income Net loss was $102.4 million, EPS Net loss per diluted share was $(0.54). Guidance raised.
  - Period: three and nine-month periods ended September 30, 2023
  - Revenue: $478.0 million
  - Net income: Net loss was $102.4 million
  - EPS: Net loss per diluted share was $(0.54)
  - Guidance: raised
  - Result: reported results
  source text: by reference in this Item 2.02. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS • Revenue was $478.0 million, a 7.9% increase over the prior year o Gross margin increased 9.4% to $147.3 million, compared to Q3 2022 • Net loss was $102.4 million, inclusive of a $105.1 million non-cash
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832332/000095017023061483/0000950170-23-061483-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.